As described in previous studies, the measurement of end-tidal breath carbon monoxide (CO) corrected for inhaled CO (ETCOc) can be used as a non-invasive index of total bilirubin production. 12 -14 Furthermore, other studies have reported a strong correlation between measurements of transcutaneous bilirubin measurements (TcB) and STB. 15 -17 Therefore, the use of the non-invasive TcB may provide an attractive alternative to serial STB measurements. It has also been suggested that measurements of cord serum total bilirubin (STB cord ) could serve as an index of fetal bilirubin production 18 and therefore may be a predictor of the development of subsequent hyperbilirubinemia. 19 Although a direct assessment of reduced bilirubin clearance due to either hepatic immaturity or enhanced enterohepatic circulation is difficult, a high level of cord serum alpha-fetoprotein (AFP cord ) has been reported to be inversely related to hepatic immaturity. 20 AFP cord has been positively correlated with peak STB in the neonatal period. Cord serum albumin (ALB cord ) has also been considered a marker of liver maturity with an inverse relationship with AFP cord and a low level in preterm infants. 20 It has been suggested that because the levels of cord blood STB reflect erythrocyte turnover and the levels of serum alpha-fetoprotein (AFP), and possibly albumin (ALB), reflect liver maturity, these parameters might be used to predict the development of hyperbilirubinemia after birth. Therefore, the objective of this study was to determine the predictive ability of these five parameters, either singly or in combination, in identifying infants at high risk for hyperbilirubinemia, which is defined as an hour-specific STB 95th percentile as defined by a nomogram.
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One hundred and fifty-one term and near-term (35 weeks) healthy Chinese newborns were studied. Sixteen (10.6%) developed hyperbilirubinemia. No significant statistical differences between the non-hyperbilirubinemic and hyperbilirubinemic groups were observed in gestational age (39±1.2 vs 38.6±1.3 weeks), birth weight (3277±377 vs 3135±313 g), male-tofemale ratio (96% vs 78%), Apgar scores >7 at 1 minute (99% vs 100%), incidence of maternal O + blood group (42% vs 50%), glucose-6-phosphate dehydrogenase (G6PD) deficiency (2% vs 6%), maternal herbal consumption (13% vs 25%), or elder siblings with hyperbilirubinemia (47% vs 50%). However, among infants with hyperbilirubinemia (n=16), there was a significantly higher incidence (81% vs 56%) of breastfeeding with or without formula supplementation. Of these infants, one was G6PD-deficient, four were found to have ABO incompatibility, one suffered from congenital pneumonia, and
another was the infant of a diabetic mother. For the remaining nine cases, no specific causes were identified except that they were breastfed. (cut-off1.7 ppm) was unsatisfactory with sensitivity of only 88% and specificity of only 48%. The combination of STB 48 (cut-off9.5 mg/dl) and ETCOc 48 (cut-off1.9 ppm) produced a sensitivity (100%) and specificity (59%). Because this combination only identifies infants at risk at 48 hours, it would not be applicable to infants considered for earlier discharge. As in previous studies, 15 -17 we found a very strong correlation between TcB and STB (r=0.86 at forehead, r=0.93 at sternum). When TcBf 48 or TcBs 48 measurements were combined with ETCO 48 , sensitivities were the same (94%), but specificities were 61% and 49%, respectively.
In summary, we conclude that the cord blood biochemical analyses for AFP, ALB, and STB are of limited value in predicting hyperbilirubinemia. In addition, no single parameter provides acceptable false-positive and false-negative rates for prediction of hyperbilirubinemia and thus should not be used as a universal predictor for safe early hospital discharge. 21 However, a combination of a timed STB and ETCOc (such as ETCOc 48 and STB 48 ) might increase the chance of identifying infants with hemolysis or other causes of increased bilirubin production as well as those with conjugation defects. Finally, replacing STB 48 with TcBf 48 provides an attractive non-invasive alternative with comparable sensitivity and specificity. 
